Symposium „Human Germline Editing – Perspectives of Global Regulation”

Wednesday, November 14, 2018

Marsilius-Kolleg, Lecture Hall, Im Neuenheimer Feld 130.1, 69120 Heidelberg

Recently, various organisations have called for an international regulation of human genome editing, particularly of interventions into the human germline with the tool CRISPR-Cas9. In the last two years, several national and international organisations have themselves adopted ethical standards that set the stage for what should and should not be allowed through this technology in an increasingly comprehensive manner. However, there is still no internationally harmonized approach to the application of genome editing in humans. The symposium will therefore focus on the benefits and limitations of international regulation. Furthermore, it aims to approach human germline editing from an interdisciplinary perspective, bringing together experts and researchers from the life sciences and biomedicine, the social sciences, law and the humanities. The Symposium is part of the Marsilius Winter School 2018 “Global Governance of Human Germline Editing” (12-17 November 2018).

Speakers:

Anne Cambon-Thomsen, University Toulouse III

Steffi Friedrichs, AcumenIST, Brussels

Rosario Isasi, University of Miami

Ursula Klingmüller, German Cancer Research Center, Member of the German Ethics Council

Jennifer Merchant, Université Paris II Panthéon Assas

Philipp Stoellger, Heidelberg University

Kathleen M. Vogel, University of Maryland

Joachim Wittbrodt, Heidelberg University

Programme:

09.00 Opening

Thomas Rausch, Director Marsilius Kolleg, Heidelberg University
Michael Boutros, German Cancer Research Center and Heidelberg University
Fruzsina Molnár-Gábor, Heidelberg Academy of Science and Humanities